Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 22nd:
eBay Inc. (EBAY - Free Report) : This commerce platforms operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.
eBay has a PEG ratio of 1.57 compared with 2.21 for the industry. The company possesses a Growth Score of B.
Merck & Co., Inc. (MRK - Free Report) :This healthcare solutions provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Merck has a PEG ratio of 1.73, compared with 1.92 for the industry. The company possesses a Growth Score of B.
Magellan Health, Inc. : This healthcare management services provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Magellan Health has a PEG ratio of 0.73, compared with 1.35 for the industry. The company possesses a Growth Score of A.
AmerisourceBergen Corporation : This pharmaceutical products distributor, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
AmerisourceBergen has a PEG ratio of 1.67, compared with 1.75 for the industry. The company possesses a Growth Score of A.
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 22nd:
eBay Inc. (EBAY - Free Report) : This commerce platforms operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.
eBay has a PEG ratio of 1.57 compared with 2.21 for the industry. The company possesses a Growth Score of B.
Merck & Co., Inc. (MRK - Free Report) :This healthcare solutions provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Merck has a PEG ratio of 1.73, compared with 1.92 for the industry. The company possesses a Growth Score of B.
Magellan Health, Inc. : This healthcare management services provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Magellan Health has a PEG ratio of 0.73, compared with 1.35 for the industry. The company possesses a Growth Score of A.
AmerisourceBergen Corporation : This pharmaceutical products distributor, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
AmerisourceBergen has a PEG ratio of 1.67, compared with 1.75 for the industry. The company possesses a Growth Score of A.
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MRK - FREE
Get the latest research report on EBAY - FREE